Results 181 to 190 of about 35,844 (248)

Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX). [PDF]

ESMO Open
Link T, Reinisch M, Just M, Untch M, Filmann N, Stötzer O, Denkert C, Bjelic-Radisic V, Wimberger P, Thill M, Rhiem K, Huober J, Solbach C, Hanusch C, Engels K, Fasching PA, Schneeweiss A, Nekljudova V, Holtschmidt J, Blohmer JU, Loibl S.   +20 more
europepmc   +1 more source

Teriparatide and denosumab treatment for pregnancy and lactation-associated osteoporosis with multiple vertebral fractures: A case study

, 2017
Akifumi Ijuin, Hiromi Yoshikata, Ryoko Asano, Taku Tsuburai, Ritsuko Kikuchi, Hideya Sakakibara   +5 more
openalex   +1 more source

Erratum to: Osteonecrosis of the jaw (ONJ) in renal cell cancer patients after treatment including zoledronic acid or denosumab [PDF]

, 2014
Vittorio Fusco, Alberto Bedogni, Giuseppina Campisi   +2 more
openalex   +1 more source

Preliminary analysis of combined romosozumab and denosumab versus teriparatide and denosumab on bone mineral density. [PDF]

Osteoporos Sarcopenia
Chiang MH, Fan TS, Lee CC, Tseng TH, Yen HK, Hung CC, Lu YC, Sie NH, Wang CY, Fu SH.   +9 more
europepmc   +1 more source

Combined Approach (Surgery + Systemic Adjuvant Therapy) in a Giant Cell Tumor of Proximal Femur: A Rare Case Report. [PDF]

J Orthop Case Rep
Mohandas P, Magadum SD, Manickavasagam M.   +2 more
europepmc   +1 more source

Case report: Recurrent severe hypocalcemia secondary to denosumab in a patient with chronic kidney disease [PDF]

Margarida Cristina Camacho Pestana Correia, Paulo Pereira, Carla Campinho Ferreira, Marcos Cerqueira, Diogo Esperança Almeida   +4 more
openalex   +1 more source

Digital twin simulations with a micro-multiphysics agent-based model reveal key drivers of bone loss after denosumab discontinuation. [PDF]

Front Bioeng Biotechnol
Ledoux C, Kendall JJ, Boaretti D, Müller R, Collins CJ.   +4 more
europepmc   +1 more source

The comparative efficacy of 12-mo of alendronate and raloxifene in maintaining denosumab-induced improvement in peripheral volumetric BMD, microarchitecture, and estimated strength

Benjamin Z. Leder, Joy N. Tsai, Sabashini K. Ramchand, Mackenzie Jordan, Hang Lee   +4 more
openalex   +1 more source

Postoperative Denosumab Therapy in Aneurysmal Bone Cysts and Osteoblastomas: A Case Series and Review of Current Literature [PDF]

Arın Celayir, Erdem Şahin, M. Ozsahin, Hüseyin Botanlıoğlu   +3 more
openalex   +1 more source

Postmenopausal Osteoporosis: From Molecular Pathways to Therapeutic Targets-A Mechanism-to-Practice Framework Integrating Pharmacotherapy, Fall Prevention, and Adherence into Patient-Centered Care. [PDF]

J Clin Med
Ena G, Soyfoo M.
europepmc   +1 more source